Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
Radiotherapy with or without chemotherapy is increasingly being used in the curative treatment for un-resected non-small cell lung cancer (NSCLC). But, until now, researchers had not looked at the cost-effectiveness of the treatment. In the October issue of the International Association for the Study of Lung Cancer's journal, the Journal of Thoracic Oncology (JTO), researchers compared the cost-effectiveness of different modified radiotherapy schemes and conventional fractional radiotherapy in the curative treatment of un-resected NSCLC patients.
They conclude that, "accelerated radiotherapy is almost certainly more efficient than current practice and should be recommended as standard radiotherapy for the curative treatment of un-resected NSCLC patients not receiving concurrent chemo-radiotherapy." However, they did not arrive at a conclusion for which model is most cost-effective.
The researchers looked at 10 randomized clinical trials with a population of un-resected NSCLC patients. These trials accrued a total of 2,000 patients between 1989 and 2006.
Most patients were male, aged 60-69 years, had squamous cell carcinoma and stage III disease. They found it was uncertain which modified scheme is most cost-effective and it is unclear whether the study results can be extrapolated to modified radiotherapy combined with concomitant chemotherapy. Therefore, further research comparing the cost-effectiveness of different types of modified radiotherapy and examining the role of chemotherapy might be valuable.
Despite this, the researchers say, "it is encouraged to adopt accelerated radiotherapy for the curative treatment of un-resected NSCLC patients who do not receive concurrent chemo-radiotherapy and examine its role in the context of concurrent chemo-radiotherapy."
The lead author is Dr. Bram Ramaekers. Dr. Jean-Pierre Pignon, Dr. Cecile Le Pechoux and Dr. Dirk De Ruysscher are co-authors and IASLC members.
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our Radiology / Nuclear Medicine category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
International Association for the Study of Lung Ca. "Accelerated radiotherapy more efficient than current practice for treatment of un-resected NSCLC patients." Medical News Today. MediLexicon, Intl., 7 Sep. 2013. Web.
4 Dec. 2013. <http://www.medicalnewstoday.com/releases/265697>
International Association for the Study of Lung Ca. (2013, September 7). "Accelerated radiotherapy more efficient than current practice for treatment of un-resected NSCLC patients." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact the our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/265697.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2013 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.